The Scanning Application
Our scanning application is an integrated platform for the creation, manufacturing, and distribution of patient ‘matched’ respiratory devices.
How it works.
All aspects of our service from scanning to ordering are contained within a single tablet device. Using tablets with an attached 3D scanner, our software can guide any clinician through the process of taking a scan, uploading it to our server and tracking the mask from creation to delivery.
How it works
Will the mask really be that much better than existing CPAP interfaces?
It's called the Goldilocks problem: most currently available CPAP masks come in standard sizes, but human faces do not. This leaves you with the problem of having to overtighten a mask too large for you, or cramming your face into one that's too small. By building each mask around a scan of your individual face, our mask takes the painful guesswork out of finding a mask, letting you focus on getting to sleep.
When will it be available?
We're currently in the process of submitting our device to the FDA for clearance in anticipation of receiving clearance later this year. Once our device has been cleared, you'll be able to purchase it from participating sleep providers and durable medical equipment retailers.
Will there be an opportunity to try the mask before it hits the market?
Other than during sanctioned clinical trials, while our mask is moving through the FDA approval process, we are unfortunately not permitted to pre-release versions to the public.
Will you be releasing a full-face version or other mask styles?
The first model we will be releasing is the nasal cushion. We have plans to offer several 3D versions including a nasal and full-face model, so that each patient can receive the best mask for their needs.
Will it be available outside of the United States?
OSA affects large portions of the population regardless of their residence. Our goal is to ensure as many people as possible have access to our 3D print masks, and as soon as possible. The fastest way to do that is to release in America first, and then move it through the regulatory agencies for the rest of the world soon thereafter.